Director Global Market Access & Pricing, frexalimab
Core
Develop global pricing and market access strategies for frexalimab, a first-in-class anti-CD40L antibody for Multiple Sclerosis (MS), to secure payer value recognition and sustainable access.
Role type
Director, Global Market Access & Pricing
Builds
Market access plans, payer value stories, global pricing policies, contracting strategies, and country launch sequencing for frexalimab.
Domain
Biopharma, Neurology (Multiple Sclerosis), Market Access & Pricing
Required skills
Pricing strategy, market access strategy, payer ecosystem knowledge, scenario planning, digital/AI tool adoption, evidence generation planning, financial analysis, cross-functional collaboration
Preferred skills
Advanced degree, experience in MS/neurology, experience with multiple payer archetypes, US healthcare system expertise
Technologies
Digital and AI-enabled tools for payer engagement
Responsibilities
Drive development of key pricing & market access deliverables; shape the MS ecosystem to drive payer value recognition; generate actionable payer insights through primary research; contribute to strategy and scenario planning; champion adoption of digital/AI tools; ensure engagement from countries; work with Evidence for Access to secure evidence generation plans; maintain deep knowledge of MS and payer ecosystems.
Seniority
Director, strategic leadership with hands-on execution